Breaking Finance News

Cardinal Health Inc (NYSE:CAH) has been downgraded to Neutral in a report by Cleveland Research today.

Yesterday Cardinal Health Inc (NYSE:CAH) traded 0.20% higher at $76.68. The company’s 50-day moving average is $78.45 and its 200-day moving average is $80.18. The last stock close price is down -4.53% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same time. 497,955 shares of the stock were exchanged, down from an average trading volume of 2,133,630

Cleveland Research has downgraded Cardinal Health Inc (NYSE:CAH) to Neutral in a report released on Monday October 10, 2016.

See Chart Below

Cardinal Health Inc (NYSE:CAH)

Cardinal Health Inc has a 52 week low of $73.25 and a 52 week high of $91.23 with a P/E ratio of 17.72 The company’s market cap is currently $0.

In addition to Cleveland Research reporting its target price, a total of 15 firms have reported on the stock. The consensus target price is $91.93 with 7 firms rating the stock a strong buy, 5 firms rating the stock a buy, 7 firms rating the stock a hold, 0 firms rating the stock a underperform, and finally 0 firms rating the stock a sell.

About Cardinal Health Inc (NYSE:CAH)

Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies. The Medical segment distributes a range of medical, surgical and laboratory products, and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers. This segment also manufactures, sources and develops its own Cardinal Health brand medical and surgical products. It provides post-acute care management and transition services, and software to hospitals.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *